Author Topic: Ocrevus the first-line DMT for RRMS among neurologists surveyed  (Read 41 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8246
  • MS diagnosed 1980
  • Location: Pacific Northwest
Ocrevus the first-line DMT for RRMS among neurologists surveyed
« on: September 21, 2018, 07:18:16 am »
It's clear from this article in Multiple Sclerosis News Today (September 21, 2018) that the drug companies are keenly aware that those with SPMS represent a largely untapped potential market and are trying hard to find something to offer.  It's also clear that the success Ocrevus is currently enjoying seems to be at least partly due to the extensive marketing campaign to promote it for very early treatment of MS.


https://multiplesclerosisnewstoday.com/2018/09/21/ocrevus-climbs-as-first-line-dmt-for-rrms-among-neurologists-surveyed-in-spherix-report/
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
36 Views
Last post March 12, 2017, 03:27:10 pm
by agate
0 Replies
58 Views
Last post April 23, 2017, 03:47:31 pm
by agate
1 Replies
104 Views
Last post August 21, 2017, 05:28:11 pm
by agate
1 Replies
84 Views
Last post June 29, 2018, 09:17:32 pm
by agate
0 Replies
17 Views
Last post May 22, 2019, 03:06:33 pm
by agate